Collagen has become one of the fastest-growing categories on the UK pharmacy supplement shelf. Powders, drinkable shots, capsules and chews all promise some combination of firmer skin, thicker hair and less joint pain. The marketing is confident. The clinical evidence, once you cut through the sponsored studies, is more modest.
This is a 2026 pharmacy-counter summary of what collagen supplements are, what the best trial evidence suggests, and where the claims still outrun the data.
What a collagen supplement actually is
Collagen is the structural protein found throughout skin, bone, cartilage, tendons and blood vessels. Pharmacy supplements are not intact collagen — swallowed intact, collagen would be broken down like any other protein. Most products contain hydrolysed collagen peptides, short amino-acid chains produced by enzymatic digestion of bovine, porcine, fish or chicken collagen.
The theory behind supplementation is that certain peptides — particularly prolyl-hydroxyproline and hydroxyprolyl-glycine — survive digestion in bioactive form, are absorbed intact, and reach the skin and joints where they stimulate fibroblast and chondrocyte activity. There is some supportive laboratory evidence for this mechanism. Whether it translates into clinically meaningful outcomes in real patients is where the debate sits.
Skin: the strongest-but-still-modest story
Skin is the endpoint with the most published evidence, partly because trials are short and outcomes measurable.
Several randomised, placebo-controlled trials of hydrolysed collagen peptides (typically 2.5–10 g/day for 8–12 weeks) have reported small improvements in:
- Skin hydration
- Skin elasticity
- Fine wrinkle depth
Meta-analyses pooling these trials generally show a statistically significant but clinically modest effect. Most trials were industry-sponsored. Washout periods were short. Effects after stopping supplementation have not been well characterised — it is unclear whether gains persist or fade.
A reasonable counter line: the evidence is not zero, but it is not transformative either. A customer investing in a daily powder for three months should expect subtle rather than dramatic changes, and the best-evidenced benefit is to skin hydration rather than deep wrinkles. Sunscreen and not smoking remain the two interventions with by far the biggest effect on skin ageing.
Joints: osteoarthritis evidence is mixed at best
The joint-health story rests on trials of both hydrolysed collagen peptides (often marketed as type I) and undenatured type II collagen (UC-II) for knee osteoarthritis.
The evidence picture:
- Several small trials have reported modest improvements in pain or function scores with daily collagen hydrolysate in osteoarthritis of the knee.
- UC-II trials have reported benefit in joint-comfort outcomes in recreational athletes.
- UK NICE guidance on osteoarthritis, summarised in the CKS osteoarthritis topic, does not recommend collagen supplements as a treatment for osteoarthritis. Neither does it recommend glucosamine or chondroitin.
For a pharmacy customer with diagnosed osteoarthritis, the evidence-based answer is weight management, exercise, topical NSAIDs and, where appropriate, paracetamol or short courses of oral NSAIDs — not a collagen supplement. Collagen may produce a subjective benefit for some, and at the usual doses it is not dangerous, but it should not be sold as a treatment for the condition.
Hair and nails
Human trial evidence for collagen in hair and nail growth is the thinnest of the three use cases. A small number of open-label and low-quality randomised studies have reported improved nail growth and reduced brittleness. Hair claims typically extrapolate from skin data or rely on before-and-after photography rather than controlled trials.
In the absence of a plausible deficiency (collagen is not a deficiency state in adults eating a normal diet), routine collagen supplementation to grow hair is not well supported. Iron deficiency, thyroid disease and postpartum telogen effluvium are far more common correctable causes of hair thinning, and a pharmacy conversation is better spent ruling those in or out.
Bone
A small number of longer-term trials have examined collagen peptides in postmenopausal women with osteopenia, reporting modest effects on bone mineral density markers. The evidence is not strong enough to position collagen as an alternative to calcium, vitamin D, weight-bearing exercise or bone-active medication where those are indicated.
Practical points at the counter
| Customer ask | Evidence-based counter answer |
|---|---|
| "Will collagen stop my wrinkles?" | Trials show small improvements in skin hydration and elasticity. Not a substitute for sunscreen. |
| "Will it help my osteoarthritic knee?" | NICE does not recommend it. Weight management, exercise, topical NSAIDs are the evidence-based path. |
| "Will it thicken my hair?" | Evidence is thin. Iron, thyroid and postpartum causes are worth investigating first. |
| "Can I have it in pregnancy?" | Limited data; no known specific risk, but not routinely recommended. Avoid very high doses. |
Dose range — most trials used 2.5–10 g/day of hydrolysed peptides. There is no established clinical dose for UK supplementation. More is not necessarily better.
Safety — hydrolysed collagen is generally well tolerated. Mild digestive upset is the commonest complaint. Patients with fish or shellfish allergy should avoid marine collagen. Collagen is a protein, and high daily intake contributes to total protein load, which matters in advanced kidney disease.
Quality — UK supplements are regulated as foods, not medicines, by the Food Standards Agency. Halal, kosher and vegan sources exist; true vegan "collagen builders" contain amino acids and vitamin C rather than collagen itself.
Red flags that trump the sale
Collagen is not a reason to delay investigation of:
- Unexplained hair loss with fatigue or weight change — rule out thyroid disease and iron deficiency.
- Progressive joint pain with stiffness and swelling — rule out inflammatory arthritis.
- Sudden skin changes — rule out dermatological disease.
Recommend a GP review first in any of these cases, as the counter refusal rules suggest.
Further reading on PharmSee
- Topical NSAID gels for musculoskeletal pain
- Vitamin D in UK adults: NHS guidance and pharmacy advice
- When a pharmacist refuses to supply: OTC red flags
Find a UK community pharmacy on PharmSee.
Sources and caveats
Content drawn from the NICE CKS osteoarthritis topic, NHS patient information, UK Expert Group on Vitamins and Minerals and the Food Standards Agency. Much of the clinical trial evidence is industry-sponsored and short-term; readers should weigh modest effects against cost. This article is general pharmacy guidance, not personalised medical advice.